Category: New products
-
AI Process Discovers, Tests Fibrosis Drug in 18 Months
A provider of drug discovery services based on artificial intelligence says in 18 months it identified and tested in mice a new drug for a chronic lung disease.
-
Synthetic RNA Start-Up Gains $80M in Early Funds
A start-up company, spun off from a biomedical engineering lab at MIT, is raising $80 million for therapies made from synthetic circular RNA.
-
Gene-Editing Biotech Acquires DNA Bar Code Company
A developer of therapies using highly precise gene editing is acquiring a company delivering gene therapies identified with DNA bar codes.
-
ALS Trial Results Deemed Insufficient for FDA Approval
An ALS treatment developer says the Food and Drug Administration advised the company’s clinical trial data would likely not support approval for patient use.
-
New Trial Testing Reformulated Covid-19 Vaccine
Two drug makers are beginning a clinical trial to test their reformulated vaccine against Covid-19 disease, particularly among older populations.
-
Novavax Providing 1.1B Vaccine Doses to Global Group
Novavax, developer of a vaccine to prevent Covid-19 disease, is providing 1.1 billion doses of its vaccine for distribution to lower resource regions.
-
Crispr-Edited Bananas Get Industry Funding
A popular type of banana, genetically edited to resist a soil fungus that threatens this fruit worldwide, is now backed by a major American food brand.
-
Photo Algorithms Find Cancerous Melanoma Lesions
An engineering team designed artificial intelligence techniques with image analysis to identify early signs of skin cancer in ordinary photographs.
-
Wearable Sensor Patch Records Multiple Health Measures
An engineering team developed a transparent thin film sensor patch that measures several vital signs for monitoring heart disease and diabetes.
-
AI Cell Analysis Start-Up Raises $6M Seed Funds
A new enterprise using artificial intelligence to analyze individual cells for immune-related diagnostics and therapies is raising $6 million in seed funds.